Wells Fargo & Company Collegium Pharmaceutical, Inc Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

A detailed history of Wells Fargo & Company transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Wells Fargo & Company holds 20,619 shares of COLL stock, worth $587,022. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,619
Previous 30,606 32.63%
Holding current value
$587,022
Previous $1.18 Million 50.08%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$28.61 - $41.86 $285,728 - $418,055
-9,987 Reduced 32.63%
20,619 $590,000
Q3 2024

Nov 13, 2024
BUY
$31.4 - $39.07 $441,892 - $549,832
14,073 Added 85.12%
30,606 $1.18 Million
Q2 2024

Aug 13, 2024
SELL
$31.36 - $39.99 $56,448 - $71,982
-1,800 Reduced 9.82%
16,533 $532,000
Q1 2024

May 10, 2024
BUY
$31.23 - $40.91 $229,353 - $300,443
7,344 Added 66.83%
18,333 $711,000
Q4 2023

Feb 09, 2024
SELL
$21.16 - $30.8 $5,945 - $8,654
-281 Reduced 2.49%
10,989 $338,000
Q3 2023

Nov 13, 2023
SELL
$21.23 - $24.28 $190,390 - $217,743
-8,968 Reduced 44.31%
11,270 $251,000
Q2 2023

Aug 15, 2023
BUY
$21.06 - $24.0 $107,069 - $122,016
5,084 Added 33.55%
20,238 $434,000
Q1 2023

May 12, 2023
BUY
$23.0 - $29.88 $269,445 - $350,044
11,715 Added 340.65%
15,154 $363,000
Q4 2022

Feb 13, 2023
SELL
$16.14 - $23.55 $17,415 - $25,410
-1,079 Reduced 23.88%
3,439 $79,000
Q3 2022

Nov 14, 2022
SELL
$15.46 - $20.1 $3,602 - $4,683
-233 Reduced 4.9%
4,518 $72,000
Q2 2022

Aug 12, 2022
SELL
$14.22 - $20.88 $961,897 - $1.41 Million
-67,644 Reduced 93.44%
4,751 $84,000
Q1 2022

May 16, 2022
SELL
$17.2 - $22.5 $338,771 - $443,160
-19,696 Reduced 21.39%
72,395 $1.47 Million
Q4 2021

Feb 14, 2022
SELL
$17.5 - $21.35 $716,012 - $873,535
-40,915 Reduced 30.76%
92,091 $1.72 Million
Q3 2021

Nov 15, 2021
BUY
$17.75 - $25.39 $111,967 - $160,160
6,308 Added 4.98%
133,006 $2.63 Million
Q2 2021

Aug 16, 2021
SELL
$21.74 - $25.28 $345,666 - $401,952
-15,900 Reduced 11.15%
126,698 $3 Million
Q1 2021

May 13, 2021
BUY
$19.25 - $26.1 $627,261 - $850,468
32,585 Added 29.62%
142,598 $3.38 Million
Q4 2020

Feb 09, 2021
BUY
$17.83 - $22.29 $128,732 - $160,933
7,220 Added 7.02%
110,013 $2.2 Million
Q3 2020

Nov 05, 2020
BUY
$15.78 - $20.82 $214,655 - $283,214
13,603 Added 15.25%
102,793 $2.14 Million
Q2 2020

Aug 13, 2020
BUY
$15.49 - $23.51 $204,886 - $310,966
13,227 Added 17.41%
89,190 $1.56 Million
Q1 2020

May 14, 2020
BUY
$13.89 - $25.45 $1.06 Million - $1.93 Million
75,963 New
75,963 $1.24 Million

Others Institutions Holding COLL

# of Institutions
247
Shares Held
37.4M
Call Options Held
59.3K
Put Options Held
9.5K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $972M
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email